Matt WillemsenScientists Discover That Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
A new study conducted by researchers at NYU Grossman School of Medicine suggests that an experimental drug, previously tested for the potential treatment of cancer, lung, and Alzheimer’s disease, could help slow down the progression of atherosclerosis that leads to heart disease.
https://scitechdaily.com/scientists-discover-that-experimental-cancer-drug-may-slow-inflammation-linked-to-heart-disease/ #CancerDrug #HeartDisease #ReverseEngineering #saracatinib
A new study conducted by researchers at NYU Grossman School of Medicine suggests that an experimental drug, previously tested for the potential treatment of cancer, lung, and Alzheimer’s disease, could help slow down the progression of atherosclerosis that leads to heart disease.
https://scitechdaily.com/scientists-discover-that-experimental-cancer-drug-may-slow-inflammation-linked-to-heart-disease/ #CancerDrug #HeartDisease #ReverseEngineering #saracatinib
Scientists Discover That Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
Potential new therapy emerges from"reverse-engineering" an existing compound. A new study conducted by researchers at NYU Grossman School of Medicine suggests that an experimental drug, previously tested for the potential treatment of cancer, lung, and Alzheimer’s disease, could help slow down the